Component

Human microbiome/metabolome response to aspartame

Context-specific entity; species, compartment and exposure are stated on each claim.

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. The 120-person six-arm sweetener trial reported distinct microbiome and metabolome changes across the sweetener groups, including aspartame, over two weeks.

    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Randomized human trial; aspartame arm compared with glucose-vehicle and no-supplement controls.
    limitations
    Total sample is not the aspartame-arm sample; no specific causal aspartame microbial metabolite is identified here.
    nutrient_topic
    Aspartame collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Aspartame
    plain_language
    A biological change need not equal a harmful clinical outcome.
    primary_references
    Personalized microbiome-driven effects of non-nutritive sweeteners on human glucose tolerance. · 2022 · https://pubmed.ncbi.nlm.nih.gov/35987213/ · DOI 10.1016/j.cell.2022.07.016

    Aspartame: digestion, taste, metabolite dependencies and experimental signaling (2026-09-20) · lines 290–296

    AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Randomized human trial; aspartame arm compared with glucose-vehicle and no-supplement controls. · source_derived_draft · unverified_draft

    ## aspartame-microbiome-trial A biological change need not equal a harmful clinical outcome. The 120-person six-arm sweetener trial reported distinct microbiome and metabolome changes across the sweetener groups, including aspartame, over two weeks. Model: Randomized human trial; aspartame arm compared with glucose-vehicle and no-supplement controls. Limitations: Total sample is not the aspartame-arm sample; no specific causal aspartame microbial metabolite is identified here. Evidence access: Primary abstract Personalized microbiome-driven effects of non-nutritive sweeteners on human glucose tolerance. · 2022 · https://pubmed.ncbi.nlm.nih.gov/35987213/ · DOI 10.1016/j.cell.2022.07.016
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards